Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1997-1-17
pubmed:abstractText
1. The effect of ondansetron, a selective 5-hydroxytryptamine3 (5-HT3) receptor antagonist, was studied in morphine-addicted rats. Morphine-dependence and tolerance, induced by drinking increasing concentrations of morphine sulphate in 5% sucrose solution for 3 weeks, were demonstrated by the naloxone-precipitated withdrawal syndrome and tail flick response to a thermal noxious stimulus (water at 50 degrees C), respectively. 2. Morphine-dependence, assessed by naloxone precipitated withdrawal, was undetectable by the 6th day, when the animals drank only tap water for 7 days after the 3-week induction period. 3. When detoxified rats were offered sucrose and morphine solutions for 10 days, the recurrence of opiate solution preference with relapse to dependence and tolerance was observed. 4. Giving ondansetron (0.1 or 1 microgram kg-1; i.p.; twice daily) on the 14th day of, or 7 days prior to, the 3-week induction period reduced dependence and tolerance seen during the 3-week morphine induction and the 10-day drinking preference periods. 5. 5-Hydroxytryptamine2 (5-HT2) receptor antagonism by cyproheptadine (100 or 250 micrograms kg-1; i.p.; twice daily) did not influence morphine-dependence and tolerance. 6. These findings suggest that ondansetron may be useful for treating opiate addiction and lowering the recidivism rate.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-1426002, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-1533288, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2066767, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2140900, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2141423, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2442006, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2576143, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2875415, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2899326, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2962686, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-2969267, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-3234491, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-3416924, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-3696238, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-3936057, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-3936058, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-4545823, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-6405439, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-6539922, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-7199959, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-7311722, http://linkedlifedata.com/resource/pubmed/commentcorrection/8799580-8306073
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1044-50
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat.
pubmed:affiliation
Studies in Biomedical and Health Sciences, School of Professional and Continuing Education, University of Hong Kong, Hong Kong.
pubmed:publicationType
Journal Article